HSF1 As A Novel Prognostic Factor And Therapeutic Target In Ovarian CancerHSF1作为卵巢癌的新型预后因素和治疗靶点INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCERIF4.72025-02-010PRE
Assessment of the Impact of SARS-CoV-2 Infection on the Sexual Function of Women, Levels of Oxytocin and Prolactin: A Prospective Cohort StudyJOURNAL OF CLINICAL MEDICINEIF2.92024-04-120OAAI
Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistanceBIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCERIF8.32024-01-014PRE
Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapyFRONTIERS IN IMMUNOLOGYIF5.92022-11-1019OAAI
Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1 (vol 18, 220, 2020)JOURNAL OF TRANSLATIONAL MEDICINEIF7.52020-06-251OAAI
Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1JOURNAL OF TRANSLATIONAL MEDICINEIF7.52020-06-0128OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向